MannKind Corp. Stock
Price
Target price
€4.78
€4.78
-0.300%
-0.015
-0.300%
€8.58
02.01.26 / Tradegate
WKN: A2DMZL / Symbol: MNKD / Name: MannKind / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for MannKind
sharewise wants to provide you with the best news and tools for MannKind, so we directly link to the best financial data sources.
Financials
News
Is MannKind Stock a Buy or Sell After the CEO Sold Nearly 66,000 Shares?
On Dec. 17, 2025, Michael Castagna, Chief Executive Officer of MannKind Corporation (NASDAQ:MNKD), executed an exercise and immediate sale of 65,804 common shares for a transaction value of
MannKind (MNKD) Q2 Revenue Rises 6%
MannKind (NASDAQ:MNKD), a biopharmaceutical firm known for its inhaled insulin and pulmonary therapeutics, released its second quarter 2025 earnings on August 6, 2025. The most significant news from